{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:45:01Z","timestamp":1779893101015,"version":"3.53.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Boehringer Ingelheim Taiwan Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-024-02971-3","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T18:04:00Z","timestamp":1729188240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO)"],"prefix":"10.1186","volume":"25","author":[{"given":"Yu-Ting","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Huang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jer","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Lung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Wei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Feng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Kuang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Cheng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Huei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Lung","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Hung","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"2971_CR1","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1056\/NEJMc1914600","volume":"381","author":"BM Contreras-Garza","year":"2019","unstructured":"Contreras-Garza BM. Update on clinical aspects of COPD. N Engl J Med. 2019;381:2484\u20135.","journal-title":"N Engl J Med"},{"key":"2971_CR2","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1136\/thx.2006.062802","volume":"61","author":"A Lokke","year":"2006","unstructured":"Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61:935\u20139.","journal-title":"Thorax"},{"key":"2971_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/thx.2005.049502","volume":"61","author":"JC Hogg","year":"2006","unstructured":"Hogg JC. Why does airway inflammation persist after the smoking stops? Thorax. 2006;61:96\u20137.","journal-title":"Thorax"},{"key":"2971_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/thorax.55.1.12","volume":"55","author":"SR Rutgers","year":"2000","unstructured":"Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van Der Mark TW, Koeter GH, Timens W. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax. 2000;55:12\u20138.","journal-title":"Thorax"},{"key":"2971_CR5","doi-asserted-by":"publisher","first-page":"dju294","DOI":"10.1093\/jnci\/dju294","volume":"106","author":"MS Shiels","year":"2014","unstructured":"Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B, Kitahara CM, Furr M, Li Y, Kemp TJ, et al. Cigarette smoking and variations in systemic immune and inflammation markers. J Natl Cancer Inst. 2014;106:dju294.","journal-title":"J Natl Cancer Inst"},{"key":"2971_CR6","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1164\/rccm.200210-1179OC","volume":"167","author":"TM Wilkinson","year":"2003","unstructured":"Wilkinson TM, Patel IS, Wilks M, Donaldson GC, Wedzicha JA. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167:1090\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"2971_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/thx.2005.040519","volume":"61","author":"TS Lapperre","year":"2006","unstructured":"Lapperre TS, Postma DS, Gosman MM, Snoeck-Stroband JB, ten Hacken NH, Hiemstra PS, Timens W, Sterk PJ, Mauad T. Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax. 2006;61:115\u201321.","journal-title":"Thorax"},{"key":"2971_CR8","first-page":"2370","volume":"62","author":"SA Belinsky","year":"2002","unstructured":"Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 2002;62:2370\u20137.","journal-title":"Cancer Res"},{"key":"2971_CR9","first-page":"351","volume":"62","author":"JC Soria","year":"2002","unstructured":"Soria JC, Rodriguez M, Liu DD, Lee JJ, Hong WK, Mao L. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res. 2002;62:351\u20135.","journal-title":"Cancer Res"},{"key":"2971_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120824","volume":"10","author":"G Wang","year":"2015","unstructured":"Wang G, Wang R, Strulovici-Barel Y, Salit J, Staudt MR, Ahmed J, Tilley AE, Yee-Levin J, Hollmann C, Harvey BG, et al. Persistence of smoking-induced dysregulation of miRNA expression in the small airway epithelium despite smoking cessation. PLoS ONE. 2015;10: e0120824.","journal-title":"PLoS ONE"},{"key":"2971_CR11","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1056\/NEJM199810223391703","volume":"339","author":"P Lange","year":"1998","unstructured":"Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339:1194\u2013200.","journal-title":"N Engl J Med"},{"key":"2971_CR12","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1164\/ajrccm.153.5.8630597","volume":"153","author":"J Vestbo","year":"1996","unstructured":"Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996;153:1530\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"2971_CR13","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1056\/NEJMoa032158","volume":"350","author":"JC Hogg","year":"2004","unstructured":"Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645\u201353.","journal-title":"N Engl J Med"},{"key":"2971_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S2213-2600(19)30276-0","volume":"8","author":"EC Oelsner","year":"2020","unstructured":"Oelsner EC, Balte PP, Bhatt SP, Cassano PA, Couper D, Folsom AR, Freedman ND, Jacobs DR Jr, Kalhan R, Mathew AR, et al. Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study. Lancet Respir Med. 2020;8:34\u201344.","journal-title":"Lancet Respir Med"},{"key":"2971_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/thoraxjnl-2017-210842","volume":"73","author":"EC Oelsner","year":"2018","unstructured":"Oelsner EC, Smith BM, Hoffman EA, Folsom AR, Kawut SM, Kaufman JD, Manichaikul A, Lederer DJ, Schwartz JE, Watson KE, et al. Associations between emphysema-like lung on CT and incident airflow limitation: a general population-based cohort study. Thorax. 2018;73:486\u20138.","journal-title":"Thorax"},{"key":"2971_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1164\/rccm.201701-0050OC","volume":"196","author":"SP Bhatt","year":"2017","unstructured":"Bhatt SP, Bodduluri S, Hoffman EA, Newell JD Jr, Sieren JC, Dransfield MT, Reinhardt JM, Investigators CO. Computed tomography measure of lung at risk and lung function decline in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;196:569\u201376.","journal-title":"Am J Respir Crit Care Med"},{"key":"2971_CR17","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.3390\/jcm9113426","volume":"9","author":"JY Choi","year":"2020","unstructured":"Choi JY, Rhee CK. Diagnosis and treatment of early chronic obstructive lung disease (COPD). J Clin Med. 2020;9:3426.","journal-title":"J Clin Med"},{"key":"2971_CR18","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa1700228","volume":"377","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Zhong NS, Li X, Chen S, Zheng J, Zhao D, Yao W, Zhi R, Wei L, He B, et al. Tiotropium in early-stage chronic obstructive pulmonary disease. N Engl J Med. 2017;377:923\u201335.","journal-title":"N Engl J Med"},{"key":"2971_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1586\/17512433.2015.1058154","volume":"8","author":"AS Melani","year":"2015","unstructured":"Melani AS. Long-acting muscarinic antagonists. Expert Rev Clin Pharmacol. 2015;8:479\u2013501.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2971_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010177.pub2","author":"KM Kew","year":"2013","unstructured":"Kew KM, Mavergames C, Walters JA. Long-acting beta2-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013. https:\/\/doi.org\/10.1002\/14651858.CD010177.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"2971_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009285.pub2","author":"C Karner","year":"2014","unstructured":"Karner C, Chong J, Poole P. Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014. https:\/\/doi.org\/10.1002\/14651858.CD009285.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"2971_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12890-020-1152-8","volume":"20","author":"A Koarai","year":"2020","unstructured":"Koarai A, Sugiura H, Yamada M, Ichikawa T, Fujino N, Kawayama T, Ichinose M. Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysis. BMC Pulm Med. 2020;20:111.","journal-title":"BMC Pulm Med"},{"key":"2971_CR23","doi-asserted-by":"publisher","first-page":"1701393","DOI":"10.1183\/13993003.01393-2017","volume":"51","author":"SP Bhatt","year":"2018","unstructured":"Bhatt SP, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Martinez FJ, Newby DE, Vestbo J, et al. Cigarette smoking and response to inhaled corticosteroids in COPD. Eur Respir J. 2018;51:1701393.","journal-title":"Eur Respir J"},{"key":"2971_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1183\/09031936.00082909","volume":"35","author":"DP Tashkin","year":"2010","unstructured":"Tashkin DP, Celli B, Kesten S, Lystig T, Mehra S, Decramer M. Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. Eur Respir J. 2010;35:287\u201394.","journal-title":"Eur Respir J"},{"key":"2971_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12931-019-1112-0","volume":"20","author":"DP Tashkin","year":"2019","unstructured":"Tashkin DP, Goodin T, Bowling A, Price B, Ozol-Godfrey A, Sharma S, Sanjar S. Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies. Respir Res. 2019;20:135.","journal-title":"Respir Res"},{"key":"2971_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s41030-017-0048-0","volume":"3","author":"KYJ Sion","year":"2017","unstructured":"Sion KYJ, Huisman EL, Punekar YS, Naya I, Ismaila AS. A network meta-analysis of long-acting muscarinic antagonist (LAMA) and long-acting beta2-agonist (LABA) combinations in COPD. Pulm Ther. 2017;3:297\u2013316.","journal-title":"Pulm Ther"},{"key":"2971_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/thoraxjnl-2014-206732","volume":"71","author":"Y Oba","year":"2016","unstructured":"Oba Y, Sarva ST, Dias S. Efficacy and safety of long-acting beta-agonist\/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis. Thorax. 2016;71:15\u201325.","journal-title":"Thorax"},{"key":"2971_CR28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2147\/COPD.S130482","volume":"12","author":"GJ Rodrigo","year":"2017","unstructured":"Rodrigo GJ, Price D, Anzueto A, Singh D, Altman P, Bader G, Patalano F, Fogel R, Kostikas K. LABA\/LAMA combinations versus LAMA monotherapy or LABA\/ICS in COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2017;12:907\u201322.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2971_CR29","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1513\/AnnalsATS.201912-915OC","volume":"17","author":"MJ Mammen","year":"2020","unstructured":"Mammen MJ, Pai V, Aaron SD, Nici L, Alhazzani W, Alexander PE. Dual LABA\/LAMA therapy versus LABA or LAMA monotherapy for chronic obstructive pulmonary disease. A systematic review and meta-analysis in support of the American Thoracic Society clinical practice guideline. Ann Am Thorac Soc. 2020;17:1133\u201343.","journal-title":"Ann Am Thorac Soc"},{"key":"2971_CR30","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2147\/COPD.S353799","volume":"17","author":"MJ Hsieh","year":"2022","unstructured":"Hsieh MJ, Chen NH, Cheng SL, Tao CW, Wei YF, Wu YK, Chan MC, Liu SF, Hsu WH, Yang TM, et al. Comparing clinical outcomes of tiotropium\/olodaterol, umeclidinium\/vilanterol, and indacaterol\/glycopyrronium fixed-dose combination therapy in patients with chronic obstructive pulmonary disease in Taiwan: a multicenter cohort study. Int J Chron Obstruct Pulmon Dis. 2022;17:967\u201376.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2971_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/clinpract12010006","volume":"12","author":"M Spielmanns","year":"2022","unstructured":"Spielmanns M, Schildge S, Diedrich JP, Valipour A. Therapeutic success in swiss COPD patients receiving dual bronchodilation therapy as COPD maintenance treatment. Clin Pract. 2022;12:46\u201356.","journal-title":"Clin Pract"},{"key":"2971_CR32","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2147\/COPD.S291920","volume":"16","author":"A Valipour","year":"2021","unstructured":"Valipour A, Avdeev S, Barczyk A, Bayer V, Fridlender Z, Georgieva M, Kudela O, Medvedchikov A, Miron R, Sanzharovskaya M, et al. Therapeutic success of tiotropium\/olodaterol, measured using the clinical COPD Questionnaire (CCQ), in routine clinical practice: a multinational non-interventional study. Int J Chron Obstruct Pulmon Dis. 2021;16:615\u201328.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2971_CR33","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34:648\u201354.","journal-title":"Eur Respir J"},{"key":"2971_CR34","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2147\/COPD.S77368","volume":"10","author":"M Cazzola","year":"2015","unstructured":"Cazzola M, Hanania NA, MacNee W, Rudell K, Hackford C, Tamimi N. A review of the most common patient-reported outcomes in COPD\u2013revisiting current knowledge and estimating future challenges. Int J Chron Obstruct Pulmon Dis. 2015;10:725\u201338.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2971_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.rmed.2019.07.019","volume":"155","author":"DP Tashkin","year":"2019","unstructured":"Tashkin DP, Goodin T, Bowling A, Price B, Ozol-Godfrey A, Sharma S, Sanjar S. Effect of smoking status on lung function, patient-reported outcomes, and safety among patients with COPD treated with indacaterol\/glycopyrrolate: pooled analysis of the FLIGHT1 and FLIGHT2 studies. Respir Med. 2019;155:113\u201320.","journal-title":"Respir Med"},{"key":"2971_CR36","first-page":"CD012066","volume":"2","author":"N Horita","year":"2017","unstructured":"Horita N, Goto A, Shibata Y, Ota E, Nakashima K, Nagai K, Kaneko T. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2017;2:CD012066.","journal-title":"Cochrane Database Syst Rev"},{"key":"2971_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12890-021-01403-y","volume":"21","author":"M Muraki","year":"2021","unstructured":"Muraki M, Kunita Y, Shirahase K, Yamazaki R, Hanada S, Sawaguchi H, Tohda Y. A randomized controlled trial of long-acting muscarinic antagonist and long-acting beta2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2021;21:26.","journal-title":"BMC Pulm Med"},{"key":"2971_CR38","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/bcp.15390","volume":"88","author":"M Cazzola","year":"2022","unstructured":"Cazzola M, Page C, Rogliani P, Calzetta L, Matera MG. Dual bronchodilation for the treatment of COPD: from bench to bedside. Br J Clin Pharmacol. 2022;88:3657\u201373.","journal-title":"Br J Clin Pharmacol"},{"key":"2971_CR39","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2147\/COPD.S96790","volume":"11","author":"HP Chan","year":"2016","unstructured":"Chan HP, Mukhopadhyay A, Chong PL, Chin S, Wong XY, Ong V, Chan YH, Lim TK, Phua J. Prognostic utility of the 2011 GOLD classification and other multidimensional tools in Asian COPD patients: a prospective cohort study. Int J Chron Obstruct Pulmon Dis. 2016;11:823\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2971_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1164\/rccm.201707-1363OC","volume":"197","author":"C Cabrera Lopez","year":"2018","unstructured":"Cabrera Lopez C, Casanova Macario C, Marin Trigo JM, de Torres JP, Sicilia Torres R, Gonzalez JM, Polverino F, Divo M, Pinto Plata V, Zulueta JJ, Celli B. Comparison of the 2017 and 2015 global initiative for chronic obstructive lung disease reports impact on grouping and outcomes. Am J Respir Crit Care Med. 2018;197:463\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"2971_CR41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12931-022-02037-2","volume":"23","author":"CF Vogelmeier","year":"2022","unstructured":"Vogelmeier CF, Worth H, Buhl R, Criee CP, Guckel E, Kardos P. Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD \u2018real world\u2019 study. Respir Res. 2022;23:109.","journal-title":"Respir Res"},{"key":"2971_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40360-020-00451-0","volume":"21","author":"CH Chen","year":"2020","unstructured":"Chen CH, Li YR, Lin SH, Chang HH, Chai WH, Chan PC, Lin CH. Tiotropium\/Olodaterol treatment reduces cigarette smoke extract-induced cell death in BEAS-2B bronchial epithelial cells. BMC Pharmacol Toxicol. 2020;21:74.","journal-title":"BMC Pharmacol Toxicol"},{"key":"2971_CR43","doi-asserted-by":"publisher","first-page":"392","DOI":"10.14740\/jocmr4542","volume":"13","author":"M Spielmanns","year":"2021","unstructured":"Spielmanns M, Tamm M, Schildge S, Valipour A. Swiss experience in therapy with dual bronchodilation in chronic obstructive pulmonary disease in relation to self-reported physical functionality. J Clin Med Res. 2021;13:392\u2013402.","journal-title":"J Clin Med Res"},{"key":"2971_CR44","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.2147\/COPD.S324467","volume":"16","author":"DA Mahler","year":"2021","unstructured":"Mahler DA, Ludwig-Sengpiel A, Ferguson GT, de la Hoz A, Ritz J, Shaikh A, Watz H. TRONARTO: a randomized, placebo-controlled study of tiotropium\/olodaterol delivered via soft mist inhaler in COPD patients stratified by peak inspiratory flow. Int J Chron Obstruct Pulmon Dis. 2021;16:2455\u201365.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2971_CR45","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1007\/s12325-022-02268-1","volume":"39","author":"A Sato","year":"2022","unstructured":"Sato A, Miyazaki A, Nakamura S. Effectiveness of tiotropium\/olodaterol in the real world: a post hoc subgroup analysis after the first year of use. Adv Ther. 2022;39:4692\u2013706.","journal-title":"Adv Ther"},{"key":"2971_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2018.09.010","volume":"144","author":"OA Oshagbemi","year":"2018","unstructured":"Oshagbemi OA, Keene SJ, Driessen JHM, Jordan R, Wouters EFM, de Boer A, de Vries F, Franssen FME. Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013. Respir Med. 2018;144:1\u20136.","journal-title":"Respir Med"},{"issue":"Suppl 2","key":"2971_CR47","first-page":"ii7","volume":"56","author":"NB Pride","year":"2001","unstructured":"Pride NB. Smoking cessation: effects on symptoms, spirometry and future trends in COPD. Thorax. 2001;56(Suppl 2):ii7\u201310.","journal-title":"Thorax"},{"key":"2971_CR48","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S2213-2600(13)70137-1","volume":"1","author":"M Thomsen","year":"2013","unstructured":"Thomsen M, Nordestgaard BG, Vestbo J, Lange P. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study. Lancet Respir Med. 2013;1:543\u201350.","journal-title":"Lancet Respir Med"},{"key":"2971_CR49","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1186\/1471-2458-14-916","volume":"14","author":"J Wang","year":"2014","unstructured":"Wang J, Li C, Jia C, Liu Y, Liu J, Yan X, Fang Y. Smoking, smoking cessation and tobacco control in rural China: a qualitative study in Shandong Province. BMC Public Health. 2014;14:916.","journal-title":"BMC Public Health"},{"key":"2971_CR50","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1186\/s12889-019-7110-9","volume":"19","author":"R Wang","year":"2019","unstructured":"Wang R, Jiang Y, Yao C, Zhu M, Zhao Q, Huang L, Wang G, Guan Y, Michael E, Zhao G. Prevalence of tobacco related chronic diseases and its role in smoking cessation among smokers in a rural area of Shanghai, China: a cross sectional study. BMC Public Health. 2019;19:753.","journal-title":"BMC Public Health"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02971-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-024-02971-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02971-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T18:08:31Z","timestamp":1729188511000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-024-02971-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2971"],"URL":"https:\/\/doi.org\/10.1186\/s12931-024-02971-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]},"assertion":[{"value":"2 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study followed the institutional guidelines of the \u201cDeclaration of Helsinki Ethical Principles\u201d for all procedures involving human participants. The study was approved by the Research Ethics Committee of National Taiwan University Hospital (201908002RSA), China Medical University Hospital (CMUH108-REC3-119), and Far Eastern Memorial Hospital (108148-E); the Institutional Review Board of Taichung Veterans General Hospital (SE19299B), Chiayi Christian Hospital (IRB2019066), Chang Gung Medical Foundation (201901282B0), E-Da Hospital (EMRP-108-105), MacKay Memorial Hospital (19CT048be), Taipei Tzu Chi Hospital (08-FS-090), and Cheng Hsin General Hospital ([727]108B-43).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"377"}}